Home/Filings/4/0001415889-24-024380
4//SEC Filing

Domzalski David 4

Accession 0001415889-24-024380

CIK 0001566044other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:15 PM ET

Size

5.2 KB

Accession

0001415889-24-024380

Insider Transaction Report

Form 4
Period: 2024-09-30
Domzalski David
DirectorPRESIDENT AND CEO
Transactions
  • Tax Payment

    Common Stock

    2024-09-30$1.88/sh685$1,288496,696 total
Footnotes (1)
  • [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Issuer

VYNE Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1
  • filerCIK 0001727794

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:15 PM ET
Size
5.2 KB